Recruiting

Dupilumab

Sponsor:

UCLA

Code:

NCT06665971

Conditions

Eosinophilic Esophagitis (EoE)

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-27. This information was provided to ClinicalTrials.gov by University of California, San Diego on 2024-12-11.